Go Pro

CareCloud (CCLD) Competitors

CareCloud logo
$2.44 +0.03 (+1.24%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$2.44 +0.00 (+0.20%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CCLD vs. BMBL, ECX, XNET, PERI, and SLP

Should you buy CareCloud stock or one of its competitors? MarketBeat compares CareCloud with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CareCloud include Bumble (BMBL), ECARX (ECX), Xunlei (XNET), Perion Network (PERI), and Simulations Plus (SLP).

How does CareCloud compare to Bumble?

Bumble (NASDAQ:BMBL) and CareCloud (NASDAQ:CCLD) are related small-cap companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings, media sentiment and analyst recommendations.

94.9% of Bumble shares are owned by institutional investors. Comparatively, 10.2% of CareCloud shares are owned by institutional investors. 15.4% of Bumble shares are owned by company insiders. Comparatively, 14.8% of CareCloud shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Bumble has a beta of 1.86, indicating that its stock price is 86% more volatile than the broader market. Comparatively, CareCloud has a beta of 1.52, indicating that its stock price is 52% more volatile than the broader market.

CareCloud has a net margin of 7.87% compared to Bumble's net margin of -72.04%. Bumble's return on equity of 32.66% beat CareCloud's return on equity.

Company Net Margins Return on Equity Return on Assets
Bumble-72.04% 32.66% 15.57%
CareCloud 7.87%24.05%16.38%

CareCloud has lower revenue, but higher earnings than Bumble. Bumble is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bumble$965.66M0.38-$693.14M-$5.84N/A
CareCloud$120.50M0.86$10.80M$0.1122.18

Bumble currently has a consensus price target of $4.33, suggesting a potential upside of 51.75%. CareCloud has a consensus price target of $3.25, suggesting a potential upside of 33.20%. Given Bumble's higher probable upside, equities research analysts clearly believe Bumble is more favorable than CareCloud.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bumble
2 Sell rating(s)
15 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.94
CareCloud
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

In the previous week, Bumble and Bumble both had 5 articles in the media. Bumble's average media sentiment score of 1.04 beat CareCloud's score of 0.07 indicating that Bumble is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bumble
4 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CareCloud
0 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Bumble and CareCloud tied by winning 7 of the 14 factors compared between the two stocks.

How does CareCloud compare to ECARX?

ECARX (NASDAQ:ECX) and CareCloud (NASDAQ:CCLD) are related small-cap companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations, media sentiment and profitability.

10.2% of CareCloud shares are held by institutional investors. 20.0% of ECARX shares are held by company insiders. Comparatively, 14.8% of CareCloud shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

CareCloud has a consensus target price of $3.25, suggesting a potential upside of 33.20%. Given CareCloud's stronger consensus rating and higher probable upside, analysts plainly believe CareCloud is more favorable than ECARX.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ECARX
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
CareCloud
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

ECARX has a beta of 0.98, suggesting that its share price is 2% less volatile than the broader market. Comparatively, CareCloud has a beta of 1.52, suggesting that its share price is 52% more volatile than the broader market.

CareCloud has a net margin of 7.87% compared to ECARX's net margin of -6.23%. CareCloud's return on equity of 24.05% beat ECARX's return on equity.

Company Net Margins Return on Equity Return on Assets
ECARX-6.23% N/A -8.48%
CareCloud 7.87%24.05%16.38%

In the previous week, CareCloud had 3 more articles in the media than ECARX. MarketBeat recorded 5 mentions for CareCloud and 2 mentions for ECARX. CareCloud's average media sentiment score of 0.07 beat ECARX's score of 0.00 indicating that CareCloud is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ECARX
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
CareCloud
0 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

CareCloud has lower revenue, but higher earnings than ECARX. ECARX is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ECARX$847.90M0.45-$66.04M-$0.15N/A
CareCloud$120.50M0.86$10.80M$0.1122.18

Summary

CareCloud beats ECARX on 14 of the 16 factors compared between the two stocks.

How does CareCloud compare to Xunlei?

CareCloud (NASDAQ:CCLD) and Xunlei (NASDAQ:XNET) are related small-cap companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations.

In the previous week, CareCloud had 3 more articles in the media than Xunlei. MarketBeat recorded 5 mentions for CareCloud and 2 mentions for Xunlei. Xunlei's average media sentiment score of 0.15 beat CareCloud's score of 0.07 indicating that Xunlei is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CareCloud
0 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Xunlei
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Xunlei has higher revenue and earnings than CareCloud. Xunlei is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CareCloud$120.50M0.86$10.80M$0.1122.18
Xunlei$462.41M0.74$1.05B$13.670.39

CareCloud presently has a consensus target price of $3.25, suggesting a potential upside of 33.20%. Given CareCloud's stronger consensus rating and higher possible upside, equities analysts plainly believe CareCloud is more favorable than Xunlei.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareCloud
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
Xunlei
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

10.2% of CareCloud shares are owned by institutional investors. Comparatively, 5.1% of Xunlei shares are owned by institutional investors. 14.8% of CareCloud shares are owned by insiders. Comparatively, 21.7% of Xunlei shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

CareCloud has a beta of 1.52, suggesting that its share price is 52% more volatile than the broader market. Comparatively, Xunlei has a beta of 1.12, suggesting that its share price is 12% more volatile than the broader market.

Xunlei has a net margin of 185.71% compared to CareCloud's net margin of 7.87%. CareCloud's return on equity of 24.05% beat Xunlei's return on equity.

Company Net Margins Return on Equity Return on Assets
CareCloud7.87% 24.05% 16.38%
Xunlei 185.71%1.47%1.24%

Summary

CareCloud beats Xunlei on 10 of the 16 factors compared between the two stocks.

How does CareCloud compare to Perion Network?

Perion Network (NASDAQ:PERI) and CareCloud (NASDAQ:CCLD) are related small-cap companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, risk, profitability, media sentiment, valuation and dividends.

CareCloud has a net margin of 7.87% compared to Perion Network's net margin of -2.17%. CareCloud's return on equity of 24.05% beat Perion Network's return on equity.

Company Net Margins Return on Equity Return on Assets
Perion Network-2.17% 3.34% 2.50%
CareCloud 7.87%24.05%16.38%

In the previous week, CareCloud had 4 more articles in the media than Perion Network. MarketBeat recorded 5 mentions for CareCloud and 1 mentions for Perion Network. Perion Network's average media sentiment score of 0.75 beat CareCloud's score of 0.07 indicating that Perion Network is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Perion Network
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CareCloud
0 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Perion Network has a beta of 1.17, indicating that its stock price is 17% more volatile than the broader market. Comparatively, CareCloud has a beta of 1.52, indicating that its stock price is 52% more volatile than the broader market.

CareCloud has lower revenue, but higher earnings than Perion Network. Perion Network is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Perion Network$439.93M0.85-$7.93M-$0.25N/A
CareCloud$120.50M0.86$10.80M$0.1122.18

68.1% of Perion Network shares are owned by institutional investors. Comparatively, 10.2% of CareCloud shares are owned by institutional investors. 2.8% of Perion Network shares are owned by insiders. Comparatively, 14.8% of CareCloud shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Perion Network presently has a consensus target price of $13.88, indicating a potential upside of 45.44%. CareCloud has a consensus target price of $3.25, indicating a potential upside of 33.20%. Given Perion Network's stronger consensus rating and higher probable upside, equities research analysts plainly believe Perion Network is more favorable than CareCloud.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Perion Network
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
CareCloud
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

Summary

CareCloud beats Perion Network on 10 of the 16 factors compared between the two stocks.

How does CareCloud compare to Simulations Plus?

CareCloud (NASDAQ:CCLD) and Simulations Plus (NASDAQ:SLP) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, media sentiment, institutional ownership, risk, earnings and dividends.

CareCloud presently has a consensus target price of $3.25, suggesting a potential upside of 33.20%. Simulations Plus has a consensus target price of $17.25, suggesting a potential downside of 5.38%. Given CareCloud's stronger consensus rating and higher possible upside, analysts plainly believe CareCloud is more favorable than Simulations Plus.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareCloud
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
Simulations Plus
1 Sell rating(s)
7 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.88

10.2% of CareCloud shares are held by institutional investors. Comparatively, 78.1% of Simulations Plus shares are held by institutional investors. 14.8% of CareCloud shares are held by insiders. Comparatively, 19.1% of Simulations Plus shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Simulations Plus has a net margin of 9.88% compared to CareCloud's net margin of 7.87%. CareCloud's return on equity of 24.05% beat Simulations Plus' return on equity.

Company Net Margins Return on Equity Return on Assets
CareCloud7.87% 24.05% 16.38%
Simulations Plus 9.88%13.50%12.45%

In the previous week, CareCloud had 1 more articles in the media than Simulations Plus. MarketBeat recorded 5 mentions for CareCloud and 4 mentions for Simulations Plus. Simulations Plus' average media sentiment score of 0.37 beat CareCloud's score of 0.07 indicating that Simulations Plus is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CareCloud
0 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Simulations Plus
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

CareCloud has higher revenue and earnings than Simulations Plus. CareCloud is trading at a lower price-to-earnings ratio than Simulations Plus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CareCloud$120.50M0.86$10.80M$0.1122.18
Simulations Plus$79.18M4.66-$64.72M$0.4045.58

CareCloud has a beta of 1.52, suggesting that its stock price is 52% more volatile than the broader market. Comparatively, Simulations Plus has a beta of 1.3, suggesting that its stock price is 30% more volatile than the broader market.

Summary

CareCloud beats Simulations Plus on 9 of the 16 factors compared between the two stocks.

Get CareCloud News Delivered to You Automatically

Sign up to receive the latest news and ratings for CCLD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCLD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CCLD vs. The Competition

MetricCareCloudHealthcare Technology IndustryHealthcare SectorNASDAQ Exchange
Market Cap$103.68M$1.37B$7.16B$12.47B
Dividend YieldN/A4.75%2.60%9.45%
P/E Ratio22.18274.99282.2524.66
Price / Sales0.8661.50585.8490.58
Price / Cash3.5430.5671.2359.99
Price / Book1.744.6111.095.90
Net Income$10.80M-$25.90M$3.50B$336.31M
7 Day Performance9.91%0.35%-0.24%0.09%
1 Month Performance9.91%-4.69%-3.70%-5.18%
1 Year Performance5.63%-19.71%61.98%18.61%

CareCloud Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CCLD
CareCloud
3.3547 of 5 stars
$2.44
+1.2%
$3.25
+33.2%
+5.6%$103.68M$120.50M22.183,650
BMBL
Bumble
4.0555 of 5 stars
$2.87
-2.0%
$4.33
+50.7%
-62.5%$372.58M$965.66MN/A1,200
ECX
ECARX
0.2422 of 5 stars
$1.04
-3.7%
N/A-34.0%$370.73M$847.90MN/A1,432
XNET
Xunlei
1.4784 of 5 stars
$5.82
-0.9%
N/A+21.1%$370.47M$494.81M0.431,306
PERI
Perion Network
3.504 of 5 stars
$9.47
-1.7%
$13.88
+46.5%
-9.7%$369.61M$439.93MN/A420

Related Companies and Tools


This page (NASDAQ:CCLD) was last updated on 8/2/2026 by MarketBeat.com Staff.
From Our Partners